In one of a series of interviews with U.S. medical officials tasked with the initial fight against the coronavirus, Dr. Deborah Birx said that the country’s loss of life could have been mitigated.
Tag: Azar, Alex M II
Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
Trump Gave W.H.O. a List of Demands. Hours Later, He Walked Away.
When President Trump quit the health organization, he left a list of seven demands on the table. Here they are.
A Viral Theory Cited by Health Officials Draws Fire From Scientists
A manifesto urging reliance on “herd immunity” without lockdowns was warmly received by administration officials. But the strategy cannot stem the pandemic, many experts say.
U.S. Tries to Bolster Taiwan’s Status, Short of Recognizing Sovereignty
President Trump prefers a robust relationship with authoritarian China to one with democratic Taiwan. But other American officials aim to strengthen U.S.-Taiwan ties.
U.S. Health Secretary to Visit Taiwan, in a Move Likely to Anger Beijing
The trip by Alex M. Azar II, a rare high-level U.S. visit, is being billed as an opportunity to highlight Taiwan’s success in battling the coronavirus pandemic.
In Sudden Shift, U.S. and China Seek to Cooperate
Several of President Trump’s top aides are advising him to work with China on the coronavirus pandemic, but national security officials are skeptical the truce will hold.
China Will Admit International Experts to Help Contain Coronavirus Outbreak
As W.H.O. coordinates scientific teams, federal officials plan to expand screening of travelers from China to 20 ports of entry in the U.S.
China Will Admit International Experts to Help Contain Coronavirus Outbreak
As W.H.O. coordinates scientific teams, federal officials plan to expand screening of travelers from China to 20 ports of entry in the U.S.
Who Owns H.I.V.-Prevention Drugs? The Taxpayers, U.S. Says
In an unexpected lawsuit, federal officials claim that Gilead Sciences willfully disregarded government patents on medicines necessary to end the AIDS epidemic.